Compounded tirzepatide is prepared by licensed compounding pharmacies pursuant to a prescription and is not an FDA-approved brand-name drug
December 2, 2024: 1,300 More People File Rybelsus and Other GLP-1 Lawsuits in November The multidistrict litigation lawsuit (MDL) against Rybelsus manufacturer Novo Nordisk and other GLP-1 manufacturers has 1,300 pending lawsuits as of December 2, 2024
However, some people have complained of diarrhoea, nausea, gastrointestinal pain, vomiting, headaches, and trouble sleeping
Samantha is passionate about building meaningful relationships within the community and believes exceptional healthcare begins with trust, education, and personalized support